Brief: Nw Bio Announces Non-Dilutive Funding Of About $47.3 Mln
11/12/2018 17:46
Dec 11 (Reuters) - Northwest Biotherapeutics Inc NWBO.PK :
* NW BIO ANNOUNCES NON-DILUTIVE FUNDING OF APPROXIMATELY
$47.3
MILLION THROUGH UK PROPERTY TRANSACTION
Source text for Eikon: ID:nPreCZPv4a
Further company coverage: NWBO.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB